Oncopeptides AB today announced that David Augustsson has been appointed Director of Corporate Affairs. As part of the company leadership team, David will be responsible for corporate communications, including strengthening the relationship with its broad investor base, and also drive the effort to reshape the corporate strategy of the company and enable the execution of it.
On June 14th, Oncopeptides announced that Holger Lembrér, Chief Financial Officer (CFO) has decided to leave Oncopeptides to pursue a new role in another company. Holger was appointed CFO in January 2023. He will continue in his current role until December or until a new CFO takes office. A recruitment process will be initiated immediately.
Cras eu maximus neque. Phasellus quis sapien quam. Sed vel pharetra neque, nec ultrices ligula. Vivamus in euismod felis, at volutpat nunc. Aenean aliquam luctus odio, sit amet egestas ante accumsan vel. Quisque id est hendrerit nunc laoreet pharetra id at orci. Nunc commodo tellus vel semper sodales. Quisque at risus at justo semper scelerisque et sed elit. Quisque pulvinar fermentum turpis at congue.
Cras eu maximus neque. Phasellus quis sapien quam. Sed vel pharetra neque, nec ultrices ligula. Vivamus in euismod felis, at volutpat nunc. Aenean aliquam luctus odio, sit amet egestas ante accumsan vel. Quisque id est hendrerit nunc laoreet pharetra id at orci. Nunc commodo tellus vel semper sodales. Quisque at risus at justo semper scelerisque et sed elit. Quisque pulvinar fermentum turpis at congue.
Cras eu maximus neque. Phasellus quis sapien quam. Sed vel pharetra neque, nec ultrices ligula. Vivamus in euismod felis, at volutpat nunc. Aenean aliquam luctus odio, sit amet egestas ante accumsan vel. Quisque id est hendrerit nunc laoreet pharetra id at orci. Nunc commodo tellus vel semper sodales. Quisque at risus at justo semper scelerisque et sed elit. Quisque pulvinar fermentum turpis at congue.